| Global epidemiology of dyslipidaemias A Pirillo, M Casula, E Olmastroni, GD Norata, AL Catapano Nature Reviews Cardiology 18 (10), 689-700, 2021 | 398 | 2021 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 178 | 2021 |
| Statin use and risk of dementia or Alzheimer’s disease: a systematic review and meta-analysis of observational studies E Olmastroni, G Molari, N De Beni, O Colpani, F Galimberti, M Gazzotti, ... European journal of preventive cardiology 29 (5), 804-814, 2022 | 64 | 2022 |
| Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study M Casula, E Olmastroni, A Pirillo, AL Catapano, M Arca, M Averna, ... Atherosclerosis 277, 413-418, 2018 | 51 | 2018 |
| Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of … M Casula, E Olmastroni, M Gazzotti, F Galimberti, A Zambon, ... Pharmacological Research 160, 105060, 2020 | 48 | 2020 |
| Cardiovascular events with PCSK9 inhibitors: an updated meta-analysis of randomised controlled trials M Casula, E Olmastroni, MT Boccalari, E Tragni, A Pirillo, AL Catapano Pharmacological research 143, 143-150, 2019 | 39 | 2019 |
| Adherence to the Mediterranean diet: impact of geographical location of the observations E Mattavelli, E Olmastroni, D Bonofiglio, AL Catapano, A Baragetti, ... Nutrients 14 (10), 2040, 2022 | 28 | 2022 |
| Multilevel models to estimate carotid intima-media thickness curves for individual cardiovascular risk evaluation E Olmastroni, A Baragetti, M Casula, L Grigore, F Pellegatta, A Pirillo, ... Stroke 50 (7), 1758-1765, 2019 | 28 | 2019 |
| Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: need for customisation strategies E Olmastroni, MT Boccalari, E Tragni, F Rea, L Merlino, G Corrao, ... Pharmacological Research 155, 104514, 2020 | 26 | 2020 |
| Proprotein convertase subtilisin-kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: facts and gaps A Baragetti, D Grejtakova, M Casula, E Olmastroni, GS Jotti, GD Norata, ... Pharmacological research 130, 1-11, 2018 | 25 | 2018 |
| Impact of COVID-19 pandemic on adherence to chronic therapies: a systematic review E Olmastroni, F Galimberti, E Tragni, AL Catapano, M Casula International journal of environmental research and public health 20 (5), 3825, 2023 | 22 | 2023 |
| Gut microbiota functional dysbiosis relates to individual diet in subclinical carotid atherosclerosis A Baragetti, M Severgnini, E Olmastroni, CC Dioguardi, E Mattavelli, ... Nutrients 13 (2), 304, 2021 | 21 | 2021 |
| Twelve variants polygenic score for low‐density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with … E Olmastroni, M Gazzotti, M Arca, M Averna, A Pirillo, AL Catapano, ... Journal of the American Heart Association 11 (7), e023668, 2022 | 15 | 2022 |
| Lipoprotein (a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group C Pederiva, ME Capra, G Biasucci, G Banderali, E Fabrizi, M Gazzotti, ... Atherosclerosis 349, 233-239, 2022 | 14 | 2022 |
| How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia M Gazzotti, M Casula, E Olmastroni, M Averna, M Arca, AL Catapano Atherosclerosis Supplements 42, e35-e40, 2020 | 14 | 2020 |
| Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study M Casula, E Olmastroni, F Galimberti, E Tragni, G Corrao, L Scotti, ... Atherosclerosis 301, 1-7, 2020 | 12 | 2020 |
| MEMBERS OF THE LIPIGEN STEERING COMMETTEE, PRINCIPAL INVESTIGATORS: Coordinator center, Participant Centers, Participant Laboratories, COLLABORATORS, STUDY CENTRAL LABORATORY … M Casula, E Olmastroni, A Pirillo, AL Catapano Atherosclerosis 277, 413-418, 2018 | 12 | 2018 |
| Evaluation of lipoprotein (a) in the prevention and management of atherosclerotic cardiovascular disease: a survey among the Lipid Clinics Network AL Catapano, L Tokgözoğlu, M Banach, M Gazzotti, E Olmastroni, ... Atherosclerosis 370, 5-11, 2023 | 9 | 2023 |
| Interactions of oxysterols with atherosclerosis biomarkers in subjects with moderate hypercholesterolemia and effects of a nutraceutical combination (Bifidobacterium longum … S Cicolari, C Pavanello, E Olmastroni, MD Puppo, M Bertolotti, ... Nutrients 13 (2), 427, 2021 | 9 | 2021 |
| Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies AS Alieva, E Olmastroni, OV Reutova, OP Rotar, AO Konradi, ... Atherosclerosis Supplements 42, e41-e48, 2020 | 9 | 2020 |
